This is the authors' abstract. We don't add key points for this paper.
To the Editor: Interleukin 17 (IL-17) induces the recruitment of immune cells to peripheral tissues, a response that requires nuclear factor κB (NF-κB) activation after IL-17 receptor engagement. IL-17 also leads to the induction of many proinflammatory factors, including tumor necrosis factor alpha (TNF-α), IL-6, IL-23, and IL-1β by innate immune cells and APCs, especially dendritic cells,1 suggesting an important role for IL-17 in localizing and amplifying the inflammatory process. Furthermore, TNF-α and IL-6 are produced by T helper 17 (Th17) cells, not only support Th17 cell development, but also synergize with IL-17 to enhance the production of proinflammatory mediators.1 IL-17 as well as Th17 cells have been found to be elevated in serum and intestinal tissue from inflammatory bowel disease (IBD) patients. IL-17 was not detected in inactive IBD tissue or in other colitis.2,3 The recent discovery and characterization of Th17 and their signature cytokines (IL-17) represents a hallmark in T-cell immunobiology by providing a new, distinctive pathway for communication between adaptive and innate immunity.4 This is the first study to our best knowledge with a larger sample that explores IL-17 gene and protein expression from colonic biopsies in patients with ulcerative colitis (UC) and includes a healthy control group. In this study we evaluated the gene and protein expression of IL-17 in the colonic mucosa from 36 patients with UC (21 active and 15 in remission) and 18 healthy controls without endoscopic or histological evidence of mucosal inflammation. Gene expression of IL-17 was measured by real-time polymerase chain reaction (RT-PCR) after total RNA extraction and complementary DNA was synthesized by PCR. The following primers were used: IL-17-forward: tggggtcccaagtgacag and reverse: ggcatcatcaatgaaaacca, GADPH-forward: gcccaatacgaccaaatcc and reverse: agcca catcgctcagaca for normalization in the respective cDNA preparation. In order to determine IL-17 protein expression from intestinal biopsies from UC patients, tissues were immunostained and compared with noninflamed tissue. The detection of IL-17 protein in tissue was performed by immunohistochemistry. Peroxidase staining of paraffin-embedded tissue slides was performed using standard protocols. Briefly, after deparaffinization and demasking of antigens, endogenous peroxidases were blocked with H2O2. Slides were blocked with 10% normal serum and were incubated with avidin and biotin. Following incubation with the primary antibody overnight at 4°C, slides were incubated with the secondary, biotin-conjugated antibody. Next, they were incubated with horseradish peroxidase (HRP)-streptavidin, followed by incubation with the peroxidase substrate 30-diaminobenzidine (DAB). Our results showed a significant increased gene expression of IL-17 in the colonic mucosa from patients with active UC as compared to those UC patients in remission and healthy controls (P < 0.001), as shown in Figure 1. Gene expression of IL-17 in colonic mucosa from patients with UC (active/remission) and healthy controls and the constitutive gene GADPH. *P < 0.001. On the other hand, the percentage of IL-17-immunoreactive cells was higher in UC patients compared with healthy controls. IL-17+ cells were localized mainly in the mucosa (Fig. 2A–E) lamina propria and perivascular inflammatory infiltrates (Fig. 2D,E) but not in goblet cells, crypt lumen, or crypt branching, nor submucosa, muscularis, or serosa layers (Fig. 2A–H). These findings suggest a role of IL-17 in the pathogenesis of UC and could be considered an inflammatory marker and potential biological therapy blocking IL-17 that might be used as a therapeutic target in the future. Representative immunoperoxidase analysis of IL-17 expression in inflamed colonic tissue (E–H) and of noninflamed colonic tissue (A–D) in UC. Original magnification 20×. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com] In conclusion, IL-17 gene and protein expression were increased in patients with active UC as compared to UC in remission and healthy controls.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fonseca‐Camarillo et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: